Related Experiment Video

Updated: May 2, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K

miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways

Zhenlin Liu1, Zhongmin Jiang2, Jianyong Huang3

  • 1Department of Neurosurgery, The Fifth Central Hospital of Tianjin, Tianjin, P.R. China.

International Journal of Oncology
|March 8, 2014
PubMed

Insights

MicroRNA-7 (miR-7) suppresses glioblastoma growth by targeting key genes in the epidermal growth factor receptor (EGFR) pathway. This microRNA acts as a tumor suppressor, offering a potential new therapeutic target for malignant gliomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Epidermal growth factor receptor (EGFR) signaling is crucial for glioblastoma (GBM) progression, driving cell proliferation, survival, migration, and invasion.
  • EGFR activates downstream pathways, including PI3K/Akt and Raf/MEK/ERK, which are frequently dysregulated in GBM.

Purpose of the Study:

  • To investigate the role of microRNA-7 (miR-7) as a regulator of EGFR signaling pathways in glioblastoma.
  • To evaluate the therapeutic potential of miR-7 in glioblastoma models.

Main Methods:

  • Enforced expression of miR-7 in glioblastoma cell lines and xenograft models.
  • Analysis of downstream signaling molecules (PI3K, Akt, Raf-1, MEK, ERK, cyclin D1) and EGFR expression.
  • Assessment of cell growth, cell cycle arrest, and tumor xenograft growth inhibition.

Main Results:

  • Enforced miR-7 expression significantly reduced levels of PI3K, phosphorylated Akt, Raf-1, phosphorylated MEK, and cyclin D1, with a slight decrease in EGFR.
  • Restoration of PI3K or Raf-1 lacking the 3'-UTR partially reversed miR-7's effects on cell growth and cell cycle.
  • Transient miR-7 expression strongly inhibited glioblastoma xenograft growth in vivo.

Conclusions:

  • MicroRNA-7 acts as a tumor suppressor in glioblastoma by targeting multiple oncogenes in the EGFR downstream pathways.
  • miR-7 represents a potential novel therapeutic target for malignant gliomas.

More Related Videos

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

13.6K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K